<DOC>
	<DOCNO>NCT01811394</DOCNO>
	<brief_summary>The purpose study evaluate safety feasibility primary hypofractionated irradiation sacrococcygeal chordoma carbon ion proton use raster scan technique .</brief_summary>
	<brief_title>Ion Irradiation Sacrococcygeal Chordoma</brief_title>
	<detailed_description>The primary objective trial safety feasibility hypofractionated irradiation patient sacrococcygeal chordoma use proton carbon ion raster scan technique primary additive treatment R2 resection . The evaluation therefore base proportion treatment without Grade 3-5 toxicity ( CTCAE , version 4.0 ) 12 month treatment and/or discontinuation treatment reason primary endpoint . Local-progression free survival , overall survival quality life analyze secondary end point .</detailed_description>
	<mesh_term>Chordoma</mesh_term>
	<criteria>Histological confirmation sacrococcygeal chordoma Karnofsky performance status â‰¥ 70 % Patients age 18 80 year Macroscopic tumour ( MRI ) Written informed consent Lack macroscopic tumour Tumor extension craniocaudal direction &gt; 16cm Metal implant level tumor could influence treatment plan Inability patient lie quiet least 20 minute ( eg due pain ) Prior radiotherapy pelvic region Simultaneous participation another trial could influence result study Active medical implant without treatment approval time ion irradiation ( eg , cardiac pacemaker , defibrillator )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>sacral chordoma</keyword>
	<keyword>chordoma</keyword>
	<keyword>carbon ion therapy</keyword>
	<keyword>proton therapy</keyword>
	<keyword>hypofractionation</keyword>
</DOC>